4//SEC Filing
Ever Alpha Fund L.P. 4
Accession 0001209191-18-057433
CIK 0001581280other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 5:02 PM ET
Size
7.6 KB
Accession
0001209191-18-057433
Insider Transaction Report
Form 4
Ever Alpha Fund L.P.
10% Owner
Transactions
- Conversion
Common Stock
2018-11-02+3,294,961→ 3,294,961 total - Conversion
Series D Preferred Stock
2018-11-02−3,294,961→ 0 total→ Common Stock (3,294,961 underlying)
Footnotes (2)
- [F1]The Series D Preferred Stock has no expiration date and will convert into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering.
- [F2]Ever Glory Limited is the general partner of Ever Alpha Fund L.P. Ever Glory Limited is a wholly owned subsidiary of Guangfa Xinde Capital Management Limited. Guangfa Xinde Capital Management Limited is a wholly owned subsidiary of Guangfa Investment (Hong Kong) Company Limited. Guangfa Investment (Hong Kong) Company Limited is a wholly owned subsidiary of Guangfa Holding (Hong Kong) Corporation Limited.
Documents
Issuer
Twist Bioscience Corp
CIK 0001581280
Entity typeother
Related Parties
1- filerCIK 0001757411
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 5:02 PM ET
- Size
- 7.6 KB